Surgical outcomes of a multicenter phase II trial of neoadjuvant atezolizumab in resectable stages IB-IIIB NSCLC: Update on LCMC3 clinical trial Meeting Abstract

  

Authors:	Lee, J.; Chaft, J.; Nicholas, A.; Patterson, G.; Waqar, S.; Toloza, E.; Haura, E.; Raz, D.; Reckamp, K.; Merritt, R.; Owen, D.; Finley, D.; McNamee, C.; Blasberg, J.; Garon, E.; Mitchell, J.; Doebele, R.; Baciewicz, F.; Nagasaka, M.; Pass, H.; Johnson, A.; Phan, S.; Schulze, K.; Bunn, P. Jr; Johnson, B.; Kris, M.; Kwiatkowski, D.; Wistuba, I.; Carbone, D.; Rusch, V.
Abstract Title:	Surgical outcomes of a multicenter phase II trial of neoadjuvant atezolizumab in resectable stages IB-IIIB NSCLC: Update on LCMC3 clinical trial
Meeting Title:	20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Keywords:	neoadjuvant; immuno-oncology; early stage lung cancer
Journal Title:	Journal of Thoracic Oncology
Volume:	14
Issue:	10 Suppl.
Meeting Dates:	2019 Sept 7-10
Meeting Location:	Barcelona, Spain
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2019-10-01
Start Page:	S744
Language:	English
ACCESSION:	WOS:000492162204077
DOI:	10.1016/j.jtho.2019.08.1593
PROVIDER:	wos
Notes:	Meeting Abstract: P2.04-88 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/157500